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B  lymphocytes and  certain  subpopulations  of T  lymphocytes respond  to 
stimulation  with  antigen  by  synthesis  and  secretion  of unique  glycoproteins 
capable  of binding  the  stimulating  antigen.  In  the  case  of the  B  cell,  these 
glycoproteins are the classic antibody molecules, which have been well character- 
ized in terms of structure, function, and organization, both at the protein and 
nucleic acid levels. The antibody nature of the B cell receptor for antigen is also 
well documented (1, 2). The equivalent molecule(s) that serve as T  cell receptors 
for antigen or are secreted by T  cells in  response  to  antigen are not as  well 
characterized. Recently, however, several laboratories have reported (3-5) initial 
characterization of putative T  cell receptors for antigen on helper and cytotoxic 
T  cells.  Also  partially  characterized  are  those  biologically  active  molecules 
synthesized and secreted by suppressor T  (Ts) z cells, the suppressor T  cell factors 
(TsF). Structural characterization of these secreted molecules and their relation- 
ship to receptors for antigen on Ts cells is still incomplete, and largely descriptive 
in nature (6-1 1), however, it is known (12) that Ts cells do not use the fl chain 
of the  T  cell  receptor  used by  helper and  cytotoxic T  ceils.  In  spite  of the 
inherent difficulties in studying TsF molecules, which have very high biological 
activity in very small quantities of material (~ 10 TM units of suppressor activity per 
nanogram of protein), certain facts concerning their structural organization have 
emerged from a  variety of systems where TsF have been derived from T  cell 
hybridomas. The T  cell-derived molecules specific for the synthetic antigen, L- 
glutamic acid60-L-alanine30-L-tyrosinel0  (GAT) are composed of either one or two 
polypeptide chains,  depending on  their cellular source (9),  and are relatively 
hydrophobic  molecules  (8,  10,  1 1)  ,that  serologically  crossreact  with  serum 
antibody against  the same antigen  when analyzed with antiidiotypic antibody 
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(13,  14).  The basis  of this  latter relationship to B  cell antibody is  unclear,  but 
does not involve the transcription of shared genes (15). What is implied by these 
data is that the T  cell molecules, or GAT-TsF, also bear a  variable region. 
Recently,  Owen  (16)  and  Taniguchi  et  ai.  (17)  have  reported  a  series  of 
serological reagents that recognize determinants linked to the immunoglobulin 
heavy chain locus (Igh) on chromosome 12 in the mouse on subpopulations of T 
cells. These T  cell determinants behave in a manner suggesting a constant region, 
or a relatively conserved structure, and have been called IgT-C determinants. 
We generated a similar set of monoclonal antibodies (mAb) for use in analysis 
and dissection of the structural  relationships among the antigen-binding TsF of 
the  various  Ts cell subsets.  Herein,  we describe  the  initial  characterization of 
these reagents, their reactivity with antigen-binding TsF, and we discuss some of 
the implications of these findings in light of what is known about Ts cell subsets 
and their products.  We also describe results using these reagents to analyze Ts 
cells for the presence of antigen-binding structures in the cell membrane with 
potential receptor function. 
Materials and  Methods 
Mice.  BALB/c,  C.B20,  and  C57BL/10  mice  were  bred  in  the  Animal  Resources 
Facility of the Jewish Hospital of St. Louis, maintained on water and laboratory chow ad 
libitum, and used at 10-20 wk of age. Mice were vaccinated at 5 wk of age with the IHD- 
T  strain of vaccinia virus. 
Antigens.  GAT (45,000 tool wt) (lot 111F; Sigma Chemical Co., St. Louis, MO) was 
prepared for use as antigen in culture (18), and coupled to sheep red blood cells (SRBC) 
for use as indicator cells in the hemolytic plaque assay (19), as described. SRBC (Colorado 
Serum Co.,  Denver, CO) were used as antigen in culture and as indicator cells  in the 
plaque assay as described (20). 
Culture System and Hemolytic Plaque Assay.  Single-cell suspensions of spleen in com- 
pletely supplemented Eagle's minimal essential medium with  10%  fetal calf serum (lot 
100361; HyClone Laboratories, Logan, UT) were incubated at 6  ×  106 cells in 0.5-ml 
volumes, in  16-mm wells of a  24-well tissue culture plate (76-033-05; Linbro Chemical 
Co., Hamden, CT) for 5 d at 37°C in an atmosphere of 10% CO2, 7% 02, 83% N~, under 
modified Mishell-Dutton conditions (18, 20). Soluble GAT (2 /~g/cuiture) or l0 T SRBC 
and diluted samples of GAT-TsF were added to the spleen cells at the start of culture. 
GAT-specific IgG and SRBC-specific IgM antibody responses were assayed using the slide 
modification of the Jerne hemolytic plaque assay (18-20). Data are presented as plaque 
forming cells (PFC)/culture, or as percent suppression of control responses. 
Generation of Hybridomas.  Generation and characterization of the suppressor T  cell 
hybridomas  specific  for  GAT  have  been  described  in  detail  (7-11,  21,  22).  T  cell 
hybridomas from: (a) C57BL/10 mice, 372B3.5 single polypeptide chain GAT-TsF1, and 
372D6.5 two polypeptide chain GAT-TsF2; (b) DBA/1,258C4.4 single polypeptide chain 
GAT-TsF; (c) BI0.S, 342B1.11 single polypeptide chain GAT-pTsFI; (d) B10.Q 762B3.7 
two polypeptide chain GAT-TsF2; and (e) BALB/c, 371A 1.5 two polypeptide chain GAT- 
TsF2 were used in this study. C57BL/10 (H-2  b, Igh-I b) are responders to GAT, whereas 
DBA/1 (H-2  q, Igh-lC), BI0.S (H-2  s, Igh-lb), and B10.Q (H-2  q, Igh-I b) are nonresponders 
to GAT. 
Concanavalin  A  (Con  A)-stimulated  blasts  were  prepared  by  incubating  single-cell 
suspensions of C.B20 spleen at a concentration of 1.2 ×  107 cells/ml in RPMI  1640 with 
10% newborn calf serum and 2 #g/ml Con A (Sigma Chemical Co.) for 24 h at 37°C in 
an atmosphere of 5% CO~ in air. Cells were harvested, washed extensively with phosphate 
buffered saline (PBS) at pH  7.2, and adjusted to  l0  T cells/ml with PBS.  107 cells were 
injected intraperitoneally into BALB/c mice every 2 wk for 3-4 mo. Individual mice were 
tested for serum antibody by complement-dependent cytotoxicity (16, 17). B cell hybrid- 1046  Igh-C-LINKED  DETERMINANTS  ON  T  SUPPRESSOR  FACTORS 
omas were constructed by fusing spleen cells from BALB/c mice (H-2  d,  Igh-la), which 
had been hyperimmunized with C.B20  (H-2  d,  Igh-1 b) Con  A  blasts, with the  BALB/c- 
derived nonsecreting  myeloma Sp  2/0-Ag  14.  Individual wells were  screened  for the 
presence of antibody by enzyme-linked immunosorbent assay (ELISA), and positive wells 
were tested for the ability to be absorbed by thymocytes and splenic T  cells,  but not B 
cells from C.B20 mice. Cells from wells that were positive by these criteria were cloned 
in  soft agar,  screened  for desired  reactivity, and expanded and further characterized. 
Several clones reactive with B cells,  but not T  cells,  in C.B20 spleen were identified and 
frozen for future analysis. 
ELISA.  Isotypes of mAb were determined using an indirect ELISA. Briefly, 96-well 
ELISA plates (Fisher Scientific Co., Pittsburgh, PA) were coated with rabbit anti-mouse 
IgM, rabbit anti-mouse  IgG1, rabbit anti-mouse IgG2a, rabbit anti-mouse IgG2b, or 
rabbit anti-mouse IgG3 (Litton Bionetics Inc., Kensington, MD) at a concentration of 2 
#g/ml, followed by blocking of remaining unreacted sites with 1% bovine serum albumin 
(BSA).  Hybridoma supernatant fluids were then added to the plates and serially diluted 
in PBS containing  1% BSA and 0.01  percent NAN3. Alkaline phosphatase-coupled goat 
anti-mouse Ig was added,  followed by the substrate (p-nitrophenyl)phosphate disodium 
(Sigma Chemical Co.). Absorption at 405  nm was determined using a  Dynatech ELISA 
Reader  (Dynatech  Laboratories,  Inc.,  Alexandria,  VA).  Concentration  of antibody  in 
culture supernatant fluids was determined by comparison with an appropriately diluted 
samples of mouse Ig of known concentration. 
Preparation of CeU Populations.  B cells and T cells were obtained as cells adherent or 
nonadherent,  respectively, to goat anti-mouse  Ig plates,  as described by Wysocki and 
Sato (23).  Thymocytes and hepatocytes were obtained following dissociation of thymus 
and liver with ice-cold Hank's balanced salt solution. Cortisone-resistant thymocytes were 
those cells remaining in  the thymus 2-8 d  after intraperitoneal treatment with  2.5  mg 
hydrocortisone  21-acetate per  mouse.  Lipopolysaccharide (LPS)-stimulated blasts  were 
prepared  by  incubating  suspensions  of spleen  cells  at  a  concentration  of  1.2  ×  107 
cells/ml in RPMI 1640 with 10% newborn calf serum (lot 29121077;  M. A. Bioproducts, 
Walkersville,  MD)  and  50  #g/ml  LPS  (Sigma  Chemical  Co.)  for  3  d  at  37°C  in  an 
atmosphere of 5% CO2 in air. 
Cell Absorptions.  mAb were absorbed by incubating 100 #1 of hybridoma supernatant 
fluids with  10  7 cells from the appropriate source in V-bottom, 96-weU microtiter plates 
(76-223-05;  Linbro Chemical Co.) for 60 rain at 4°C.  Following centrifugation at  1,000 
rpm for  10  min,  the  supernatant  fluids  were removed and tested  for the  presence of 
antibody by ELISA. 
Preparation of Cell Membranes.  Cell pellets from hybridomas 372B3.5 and  372D6.5 
were washed three times with PBS, resuspended in 5 ml PBS, to which phenylmethylsul- 
fonyl fluoride and aprotinin (Sigma Chemical Co.) were added to a final concentration of 
100 #g/ml each. Cells were disrupted by 15 strokes in a  Dounce homogenizer, or until 
visual examination showed that >90% of the cells were disrupted. Nuclei and remaining 
intact  cells were  removed in  the  pellet after centrifugation  at  400 g  for  10  min;  the 
remaining sample, containing membranes, was applied to a sucrose gradient, as described 
by Kinzel and Mueler (24).  The fraction containing membranes was collected, washed, 
and the proteins were extracted on ice for 90 rain in PBS containing 0.5% Nonidet P-40 
(NP-40). Debris was removed by centrifugation at 100,000 g, and the supernatant fluid, 
which contained the extracted proteins, was used in subsequent analyses as the soluble 
membrane preparation. 
Immunoabsorbents.  BALB/c anti C.B20 T  cell mAb were coupled to CNBr-Sepharose 
4 B (Sigma Chemical Co.) according to the manufacturer's instructions. Peanut agglutinin 
(PNA)-agarose was purchased from E-Y  Laboratories, San  Mateo, CA.  Samples (GAT- 
TsF  or  soluble  membrane preparations)  were  applied  to  the  immunoabsorbents, and 
eluted with 500 mM D-galactose (Sigma Chemical Co.) in the case of PNA-agarose, or 2 
M  KCI for antibody coupled to Sepharose, and either tested for biological activity, or 
analyzed by gel electrophoresis. GAT-TsF2 were separated into isolated chains, as previ- 
ously described (9),  by reaction with  5 mM dithiothreitol  (DTT) (Sigma Chemical Co.) SORENSEN  ET  AL.  1047 
for 30 min. at 4°C, and then applying to the relevent immunoabsorbent that had been 
pre-equilibrated with 5  mM DTT; sample was eluted as before. DTT was removed by 
dialysis against PBS before subsequent immunoabsorption or biological analysis. 
Gel Electrophoresis.  Samples were analysed by sodium dodecyl sulfate-polyacrylamide 
gel  electrophoresis  (SDS-PAGE)  under  reducing  or  nonreducing  conditions,  in  15% 
polyacrylamide gels (25).  Isoelectric focusing was performed as described by Sidman (26), 
using a pH gradient of 5-8. Gels were fixed in a solution of methanol/acetic acid/water 
50:10:40 (vol/vol/vol), and stained with silver by the method of Morrisey (27). 
Results 
Generation  and  Characterization  of BALB/c  Anti-C.B20  mAb.  Hyperimmuni- 
zation  of BALB/c  mice with  Con  A  blasts  from allotype congenic  C.B20  mice 
resulted  in  low  but  significant  titers  of antibodies  reactive  in  a  complement- 
dependent  lysis assay with  thymocytes and  splenic T  cells from C.B20,  but  not 
BALB/c  mice.  Lysis  of  20-30%  of  T  cells  was  generally  observed  against 
backgrounds of 8-10%  lysis. Spleen cells from mice with the highest titers were 
fused with the nonsecreting BALB/c myeloma SP 2/0-Ag 14; the resulting clones 
were  again  screened  for  reactivity  on  splenic  T  cells  and  thymocytes.  Those 
seven clones most strongly positive were expanded, and are listed in Table I. In 
addition to the hybridomas reactive only with T  cells, several hybridomas reactive 
only with B cells (not shown) were also identified. Antibodies produced by these 
hybridomas were characterized by isotype using an indirect ELISA. The results 
of these assays are summarized in Table I. All antibodies were restricted to one 
of two  subclasses;  IgM  (1322  A2.1,  1322  B3.2,  1322  B3.3,  1322  B1.3,  1322 
B3.5)  or  IgG1  (1322  C5.3,  1322  D4.7).  Concentrations  of antibodies  ranged 
from  16 to  125 ~tg/ml (data not shown). 
Tissue Distribution of 1322 mAb.  The reactivity of BALB/c anti-C.B20  mAb 
with  a  variety  of  cell  types  was  examined.  Antibody-containing  hybridoma 
supernatant  fluids  were  absorbed  with  the  appropriate  cells,  and  were  then 
assayed for the presence of antibody by ELISA. The results of such an absorption 
TABLE  I 
Tissue Distribution of BALB/c Anti-C.B20 mAb 
Cells used for absorption 
Cortisone- 
mAb  Con A  LPS  resistant  Control 
Spleen  T cells  B cells  blasts  blasts  thymo-  Liver  (unab- 
sorbed)  cytes 
1322 A2.1 (#,k)  0.4  0.2  3.0  0.2  2.5  0.5  2.9  3.0 
1322 B3.2 (#, k)  0.75  0.8  1.6  0.5  1.5  0.6  1.6  1.6 
1322 B3.5 (#, k)  1.8  1.0  5.5  0.8  6.0  0.9  5.7  6.0 
1322 B3.3 (#, k)  2.0  0.5  2.5  0.3  2.8  1.0  3.0  3.0 
1322 C5.3  (tt, k)  2.0  0.8  12.0  0.5  11.9  1.0  12.0  12.5 
1322 D4.7 (#, k)  1.0  1.2  2.5  1.5  3.0  1.5  2.9  3.0 
1322 B1.3 (#, k)  0.2  1.5  1.9  1.0  1.8  2.9  3.0  3.0 
107 of the indicated cell type were incubated with I00 ttl of the individual BALB/c anti-C.B20 mAb 
for 90 rain at 4°C in V-bottom 96-well Linbro plates. Absorbed supernatant  fluids were collected 
and tested for presence of antibody by ELISA. Data are presented as grams of mAb remaining after 
absorption by the indicated cell type. Isotypes of mAb were determined by indirect ELISA analysis, 
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are summarized in Table I. B cells, LPS blasts, and liver failed to absorb antibody, 
whereas spleen,  T  ceils,  Con  A  blasts  from spleen, and cortisone-resistant thy- 
mocytes (except  1322  B1.3) absorbed significant amounts  of antibody.  Taken 
together, we interpret these results to indicate the 1322 mAb are T  cell-specific, 
and fail to have significant reactivity with other cell types. 
Reactivity  of 1322  mAb  with Monoclonal  GAT-TsF.  Immunoabsorbents  pre- 
pared  from  BALB/c  anti-C.B20  T  cell  mAb  were  tested  for  their  ability  to 
absorb GAT-TsF activity using a  panel  of monoclonal GAT-TsF derived from 
T  cell  hybridomas  from  mice  that  differ at  major  histocompatibility complex 
(MHC)  and  Igh  loci.  Three  basic  conclusions  can  be  made  from  the  data 
presented  in  Table  II:  (a)  six  of  the  seven  mAb  reagents  were  capable  of 
absorbing the monoclonal GAT-TsF, and all but one, mAb 1322 B3.5, absorbed 
at least two of the GAT-TsF tested; (b) the ability to be absorbed by the  1322 
mAb  required expression  of the  Igh-1 b haplotype in  the  GAT-TsF-producing 
hybridoma, but was independent of the MHC haplotype, as seen in the ability to 
absorb  GAT-TsF  from  372B3.5  (H-2  b,  Igh-lb),  372D6.5  (H-2  b,  Igh-lb), 
342B1.11  (H-2  s,  Igh-1 b)  and  762B3.7  (H-2  q,  Igh-lb),  but  not  258C4.4  (H-2  q, 
Igh-1 c) or 371A1.5 (H-2  d, Igh-la); and, (3) the mAb could be divided into those 
capable of absorbing only GAT-TsFj single-chain suppressor factors (1322 A2.1, 
and B3.2 absorbed 372B3.5 and 342B 1.11), and those capable of absorbing only 
GAT-TsF2, two-chain suppressor factors (1322  B3.3 and C5.3 absorb 372D6.5 
and 762B3.7). This point is further illustrated in Table III, in which the GAT- 
TsF1,  372B3.5  and  GAT-TsFz,  372D6.5  were sequentially absorbed  by  1322 
B3.2 and  1322  C5.3.  As can be seen in the data presented,  GAT-TsF1 is  1322 
C5.3-,  1322  B3.2 +,  while  GAT-TsF2 is  1322  C5.3 +,  1322  B3.2-.  These  data 
support the interpretation that the reagents recognize independent, nonoverlap- 
TABLE  II 
Absorption of Hybridoma-derived GAT-specific Suppressor Factors by BALB/c Anti-C.B20 mAb 
GAT-specific PFC/culture in presence of 
Immunoab-  372 B.35  372 D6.5  258 C4.4  371 A1.5  762 B3.7 
sorbent*  single-chain  two-chain  single-  342 B1.11  two-chain  two-chain 
(H_2  b,  (H_2  b,  chain  single-chain 
igh.1 b)  igh_l b)  (H-2q,  (H-2  ~, Igh-i h)  (H-2d'  (H-2q'  igh_l c)  Ig  h-la)  Igh-1  b) 
None  <10 (0)  <10 (0)  <10 (0)  <10 (0)  <10 (0)  <10 (0) 
1322 A2.]  278(117)  43(18)  <10 (0)  320(134)  <10 (0)  24(10) 
1322 B3.2  253 (106)  13 (5)  18 (8)  345 (145)  18 (8)  <10 (0) 
1322 B3.5  <10 (0)  <10 (0)  <10 (0)  <10 (0)  <10 (0)  243 (102) 
1322 B3.3  45 (19)  155 (65)  <10 (0)  <10 (0)  <10 (0)  219 (92) 
1322 C5.3  20 (8)  215 (90)  <10 (0)  <10 (0)  <10 (0)  219 (92) 
1322 D4.7  25 (11)  60 (25)  18 (8)  <10 (0)  <10 (0)  ND 
1322 B1.3  205 (86)  245 (103)  <10 (0)  ND  ND  ND 
Hybridoma-derived GAT-TsF were absorbed with the indicated immunoabsorbent before addition 
to culture at a final dilution of 1:10,000. B10 spleen cells (6 x  10  ~) were cultured with 2 #g GAT 
and GAT-TsF absorbed with the indicated immunoabsorbent; data are presented as IgG GAT- 
specific PFC/culture. Control response was 238 GAT-specific  IgG PFC/culture; percent of control 
response to GAT is in parentheses. ND, not done. 
* Culture supernatant fluids from the indicated hybridomas coupled to Sepharose 4B. SORENSEN  ET  AL. 
TABLE  III 
Sequential Absorption of Hybridoma-derived GAT-TsF  BALB/c Anti- 
C.B20 mAb 
TsF absorbed  First absorption*  Second absorption  ~ 
GAT- 
specific 
P~C/ 
culture 
None 
GAT-TsF1 
GAT-TsF2 
390 
1322 C5.3 EFF  1322 B3.2 EFF  420 
1322 C5.3 EFF  1322 B3.2 EL  <10 
1322 C5.3 EL  1322 B3.2 EFF  310 
1322 C5.3 EL  1322 B3.2 EL  330 
1322 C5.3 EL  1322 C5.3 EFF  340 
1322 B3.2 EFF  1322 C5.3 EL  410 
1322 B3.2 EL  1322 C5.3 EFF  <10 
1322  B3.2 EL  1322 C5.3 EL  418 
1322 C5.3 EFF  1322 B3.2 EFF  405 
1322 C5.3 EFF  1322 B3.2 EL  365 
1322 C5.3 EL  1322 B3.2 EFF  <10 
1322 C5.3 EL  1322 B3.2 EL  565 
1322 B3.2 EFF  1322 C5.3 EFF  325 
1322 B3.2 EFF  1322 C5.3 EL  <10 
1322 B3.2 EL  1322 C5.3 EFF  285 
1322 B3.2 EL  1322 C5.3 EL  413 
5 ×  106 B10 spleen cells were cultured with 2 #g GAT and GAT-TsF 
(1 : 10,000 final dilution) absorbed with the indicated immunoabsorbents; 
data are presented as IgG GAT-specific PFC/culture. 
* The indicated mAb coupled to CNBr-Sepharose 4 B was used to absorb 
GAT-TsF (372B3.5) or GAT-TsF2 (372D6.5). Column effluents (EFF) 
and 2.0 M KCI eluates (EL) were collected. 
* Effluent or eluate fractions from the first immunoabsorbent were ap- 
plied to the indicated second immunoabsorbent and column effluents 
(EFF), or 2.0 M KCI eluates (EL) were collected and added to culture at 
a final dilution of 1:10,000. 
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ping determinants  restricted to either TsF~ or TsF2 molecules. Finally, one mAb, 
1322  B1.3,  absorbed  both  single-chain  GAT-TsF~  (372B3.5)  and  two-chain 
GAT-TsF2  (372D6.5  and 762B3.7). 
Mapping  of Determinant(s)  Recognized  by  1322  mAb.  The  GAT-TsF2  from 
hybridoma  372D6.5  was  separated  into  its  component  antigen-binding  chain 
(ABC  ÷) and  I-J-bearing chain (I-J+), as shown  previously (9), and as described in 
Materials and Methods.  Isolated chains were then applied to Sepharose columns 
coupled with the  1322 C5.3  mAb; column effluents and  2.0 M  KC1 eluates were 
assayed  for  their  ability to  complement  the  reciprocal  unabsorbed  chain  and 
restore suppressive activity (general flow chart illustrated in Fig.  1). The  results 
of this  experiment  are  summarized  in  Table  IV.  As  seen  previously  (9),  the 
isolated antigen-binding  chain  (ABC  +,  eluate  B) and  ABC-/I-J + chain  (effluent 
A, previously shown  [9] to be the I-J  + chain) are unable to suppress individually 
(groups 3  and 4), but are highly suppressive when combined  (group 5).  Isolated 
antigen-binding  chains  and  ABC-/I-J +  chains  were  applied  to  a  1322  C5.3- 1050  Igh-C-LINKED  DETERMINANTS  ON  T  SUPPRESSOR  FACTORS 
GAT-TsF 
I 
-  h  GAT  Sep  arose 
I 
l  Eluate  B (ABC  +)  Effluent A (ABC-) 
1322-Sepharose  1322-Sepharose 
1  I 
{  °l  f  3 
Effluent  C  Eluate  D  Effluent E  Eluate  F 
(ABC~ 1322-)  (ABC~ !322  +)  (ABC  + 1322-)  (ABC  + 1322  +) 
i_j  T  i-j  + 
FIGURE  1.  GAT-TsF was applied to GAT-Sepharose in the presence or absence of 5  mM 
DTT. The effluent and 2.0  M  KCI eluate were collected and dialyzed. Effluent and eluate 
material was  then applied to a  second immunoabsorbent  composed of 1322  mAb linked to 
Sepharose, in the absence of DTT. Effluents and 2.0 M KCI eluates were collected (C-F) and 
analyzed for biological activity alone or in various combinations. 
TABLE  IV 
Reactivity of 1322 C5.3 with the Antigen-binding  Chain of the GAT- 
TsF2, 372 D6.5 
GAT-specific 
Group  Immuonabsorbent fraction added*  PFC/culture* 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
None  265 
Unfractionated 372 D6.5  <10  (1) 
ABC-/I-J+ (A)  243  (92) 
ABC  ÷ (B)  288 (109) 
ABC-/I-J+ (A) +  ABC+ (B)  <10 (1) 
ABC-/I-J  +, 1322- (C) + ABC-, 1322 + (D)  253  (95) 
ABC  ÷, 1322- (E) +  ABC  ÷, 1322 ÷ (F)  243  (92) 
ABC-/I-J  ÷, 1322- (C) +  ABC+, 1322- (E)  223  (84) 
ABC-/I-J+, 1322 + (D) + ABC+, 1322" (F)  333  (126) 
ABC  ÷, 1322-(E)+ ABC*, 1322 + (D)  228  (86) 
ABC-/I-J-, 1322- (C) +  ABC+,  1322+ (F)  <10  (2) 
* GAT-TsF~ was reduced with 5 mM DTT, and filtered through GAT- 
Sepharose; adsorbed material was eluted with 2.0 M KCI.  Effluent and 
eluate fractions were then  filtered through  1322  C5.3-Sepharose and 
eluted.  Samples  were  dialyzed  to  remove  DTT  before  addition  to 
culture. Letters in parentheses refer to the effluent and eluate fractions 
diagrammed in Fig. 1. 
Unfractionated GAT-TsF~ and isolated chains were added  to cultures 
of spleen  cells from  C57BL/10  mice at  a  final dilution  of I:10,000. 
Cultures were stimulated with 2 #g GAT; data are presented as GAT- 
specific PFC/culture. Percent of control response is in parentheses. 
Sepharose  immunoabsorbent;  effluent  and  eluates  were  collected  and  tested  in 
various combinations.  Suppression  was seen only when  ABC-/I-J + chain effluents 
from  1322  C5.3 were combined  with eluates of antigen-binding  chain from  1322 
C5.3-Sepharose  (group  11).  These  data  support  the  conclusion  that  the  Igh 
linked determinant(s)  recognized  by the  1322  C5.3  mAb  is borne  by the antigen- 
binding  chain  of GAT-TsF2. SORENSEN  ET  AL.  1051 
In a  similar fashion, localization of the determinant recognized by 1322  A.21 
on GAT-TsF2 was examined.  The  data presented  in Table V  demonstrate  two 
points: GAT-TsF1 behaves as a single polypeptide, as previously reported (9) and 
demonstrated  here  by recovery  of suppressive  activity  in  the  eluate  from  the 
GAT-Sepharose column (group 4) in the presence of DTT.  Identical results are 
seen after absorption and elution from a anti-I-J  b mAb-Sepharose column under 
the same conditions (data not shown) (9).  Second,  absorption of the  GAT-TsF1 
eluted  from  GAT-Sepharose  (or  anti-I-J-Sepharose) on  1322  A2.1-Sepharose 
(in  the  presence  of  DTT)  quantitatively  removes  suppressor  activity  that  is 
recovered in  the  2.0  M  KC! eluate,  again supporting the conclusion  that  GAT 
TsFI is composed of a  single polypeptide chain. 
Cell Membrane Analysis.  Cell  membranes were prepared  from  372B3.5  and 
372D6.5 by sucrose density gradient fractionation, and membrane proteins were 
extracted with PBS, pH 7.2, containing 0.5% NP-40, followed by centrifugation 
at 100,000 g for 30 min to remove cell debris. The extracted membrane proteins 
were applied to  1322  A2.1-Sepharose  in the  case of the GAT-TsF~-producing 
hybridoma 372B3.5,  or to  1322  C5.3-Sepharose  for the GAT-TsF2-producing 
hybridoma 372D6.5.  After incubation  for 1 h  at 4°C, samples were eluted with 
15% glycerol containing 6% SDS, and  were applied to a  12.5%  acrylamide gel. 
When  indicated,  samples  were  first  reduced  with  2-mercaptoethanol  before 
applying to  the  gel.  Individual  lanes  were  divided  into  3-mm slices  that  were 
eluted  with  PBS;  eluted  material  was  tested  for  direct  suppression  of GAT- 
specific  PFC  responses  when  material  isolated  from  372B3.5  was analyzed,  or 
for the  ability to  complement isolated  I-J  + chains  and  reconstitute  suppression 
when membrane isolates from 372D6.5 were analyzed. Results presented in Fig. 
TABLE  V 
Subunit Structure of GAT-TsFI Defined by 1322 A2.1 
GAT-specific  Group  Immunoabsorbent fraction added*  PFC/culture* 
1  None  265 
2  Unfractionated  372 B3.5  <10 (1) 
3  ABC- (A)  268 (101) 
4  ABC  + (B)  8 (3) 
5  ABC- (A) + ABC* (B)  <10 (1) 
6  ABC-, 1322-(C)  245 (92) 
7  ABC-, 1322  + (D)  318 (120) 
8  ABC  +, 1322-(E)  333 (126) 
9  ABC  +, 1322  + (F)  20 (8) 
* GAT-TsFI was equilibrated  with 5 mM DTT and applied to a GAT- 
Sepharose  column;  adsorbed  material  was eluted  with 2.0  M  KCI. 
Effluent and eluate fractions were then applied to a 1322 A2.1-Sepha- 
rose column; effluent and eluate fractions were collected. Samples were 
dialyzed to remove DTT before addition  to culture.  Letters  in paren- 
theses refer to individual effluent and eluate fractions according to the 
flow chart diagrammed in Fig. 1. 
* Unfractionated  or  fractionated  GAT-TsF1  was added  to cultures  of 
C57BL/10 spleen at a  final dilution  of 1:10,000,  and cultures  were 
stimulated  with  2  t~g  GAT.  Data  are  presented  as  GAT-specific 
PFC/culture;  percent of control response is in parentheses. 1052  Igh-C-LINKED  DETERMINANTS  ON  T  SUPPRESSOR  FACTORS 
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FIGURE 2.  Solubilized membrane proteins from 372D6.5 (A and C) and 372B3.5 (B and D) 
were applied  to  1322 C5.3-Sepharose  or  1322 A2.1-Sepharose,  respectively, eluted  with 
sample  buffer,  applied  to  a  12.5% SDS-polyacrylamide  gel,  and  electrophoresed  under 
nonreducing  (A and B) or reducing  (C and D) conditions.  Lanes containing  sample were 
divided into 3-mm slices, eluted with PBS, and individual fractions were tested for biological 
activity. Material isolated from 372B3.5 was tested for direct suppression of a GAT-specific 
PFC response, whereas material isolated from 372D6.5 was assayed by the ability to comple- 
ment  independently  isolated  I-J  + chains, and  restore antigen-specific suppressive activity. 
Molecular masses (in kD) of known proteins are indicated by arrows. Data are expressed as 
percent suppression of control. 
2, A and C show that 1322 C5.3-Sepharose absorbs a biologically active molecule 
from the  membrane of 372D6.5  that  reconstitutes  suppression  in the  presence 
of an I-J  + chain, and has an apparent molecular mass of 31.5-34 kilodaltons (kD) 
under reducing and nonreducing conditions. The discrepancy in molecular mass 
between  reduced  individual  chains  and  nonreduced  samples  is  most probably 
due  to  a  combination  of differences  in  folding  of the  reduced  molecules  and 
aberrant migration of glycoproteins in SDS-polyacrylamide gels. The molecular 
mass for the antigen  binding chain  (1322  C5.3 + chain) isolated from the  mem- 
brane of 372D6.5 appears to be ~ 10 kD larger than the equivalent chain obtained 
from the  secreted  protein  (data  not  shown).  This  discrepancy could  be due  to 
differences in glycosylation, presence of lipid, or extraneous membrane material 
covalently attached  to  the  membrane material, or  could  represent  two  unique 
molecules; one secreted, the other membrane bound. The available data do not 
allow us to address this point. Results with 372B3.5 membrane proteins absorbed 
by 1322  A2.1-Sepharose  are presented in Fig.  2, B and D. Under nonreducing 
conditions,  a  biologically active  molecule  with  an  apparent  molecular  mass  of 
48-50 kD is obtained.  Under reducing conditions,  the same sample migrates at 
a  lower molecular mass of ~24-25  kD. 
The  possibility that  the  suppressor molecule isolated from the  membrane of 
372B3.5  exists  as  a  disulfide-linked  dimer  was  partially  addressed  by  eluting 
material from 1322 A2.1-Sepharose with 2.0 M  KC1, dialyzing to remove excess 
salt  and  applying  the  sample,  after  reduction  with  2-mercaptoethanol,  to  an 
isoelectric focusing gel with a pH gradient of 3-10. The sample lane was divided 
into  3-mm slices,  eluted,  and  the  material from individual  slices was tested for 
direct suppression of GAT-specific PFC responses. The results illustrated in Fig. 
3 show that all suppressive activity focused with a single pI of 6.6. SORENSEN  ET  AL.  1053 
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F~gtmE  3.  Solubilized  membrane  proteins from  372B3.5  were  applied  to  1322  A2.1- 
Sepharose, eluted  with  2.0  M  KCI,  dialysed, and  reduced with  2-mercaptoethanol before 
applying to an isoelectric focusing gel with a pH gradient of 3-10. The lane containing sample 
was divided into 3-ram slices, e]uted with PBS, and the material was tested for antigen-specific 
suppression of a GAT-PFC response. Data are presented as percent of control. 
Discussion 
Fusion of spleen cells from BALB/c mice hyperimmunized with Con A blasts 
from allotype congenic C.B20 mice yielded a series of hybridomas secreting mAb 
reactive in an allotype-restricted manner with T  cells and not B cells.  Further 
analySis showed the determinants to be expressed on cortisone-resistant thymo- 
cytes, and  on  Con  A  blasts,  but  not  on  LPS blasts  or  hepatocytes.  In  other 
experiments  (C.  W.  Pierce,  C.  M.  Sorensen,  and J.  A.  Kapp,  manuscript  in 
preparation) these reagents were shown, individually, to react with functionally 
defined subpopulations of either Lyt-1  + or  Lyt-2  + regulatory T  cells,  but not 
with both. Using a panel of Igh-V- and Igh-C-region recombinant mice, we have 
begun mapping the positions of the genes on chromosome 12 that are involved 
in expression of these determinants. Initial results with our reagents suggest that 
the genetics are more complicated than those originally reported (28,  29), and 
will  be  the  subject  of another  report.  Immunoabsorbents made  from  these 
hybridomas absorbed  monoclonal suppressor  factors in  an  allotype-restricted 
manner, independent of MHC haplotype. These same immunoabsorbents were 
used to isolate proteins from the membranes of suppressor T  cell hybridomas 
that were capable of  suppressing in vitro antibody responses in an antigen-specific 
manner. 
Previous reports  (17,  27,  28)  have  described  antibodies raised in a  similar 
fashion that are reactive exclusively with T  cells in an allotype-restricted manner. 
In these studies (27, 28), several reagents raised against the Igh-1 e allotype were 
identified and shown to react with determinants on certain mature functional 
subsets of T  cells,  or were reactive with T  cells and thymocytes in a  manner 
reminiscent of differentiation antigens (reviewed  in  16). These  determinants 
have  been  termed  IgT-C  determinants, and  have  been  suggested as  possible 1054  Igh-C-L1NKED  DETERMINANTS  ON  T  SUPPRESSOR  FACTORS 
constant region determinants on the T  cell receptor for antigen,  based on these 
data and  on  proximity  of these apparent  structural  genes encoding a  T  cell- 
restricted antigenic determinant to the Ig constant region gene complex. Hedrick 
et al (5) have reported the cloning of a gene that appears to encode the/3 chain 
of the T  cell receptor for antigen  on cytotoxic T  cells and helper T  cells. The 
gene shows rearrangement  in the appropriate functional T  cell clones, as would 
be predicted for a functional T  cell receptor. Chromosomal mapping has placed 
the gene on chromosome 6, in linkage with the Ig light chain locus (29). These 
findings  do not preclude  our results,  which  suggest the  involvement  of genes 
linked  to  chromosome  12  in  coding  for  or  controlling  the  expression  of the 
antigen  receptor on suppressor T  cells. In fact, a  cDNA probe generated from 
the receptor gene isolated by Hedrick and coworkers (12) fails to hybridize and 
show  rearrangement  with  DNA  from  any  functional  suppressor  hybridomas 
examined to date, including several Ts cell hybridomas used in this report. This 
result, along with results of experiments showing the failure of anti-suppressor 
factor mAb to react with  T  helper  cells (C.  W.  Pierce,  C.  M.  Sorensen, J.  A. 
Kapp, manuscript  in preparation),  suggests that  the receptor structure  on sup- 
pressor T  cells may be distinct  from that  found on helper cells and  cytotoxic 
cells, and in fact, may use entirely different genes. This is also suggested by the 
failure of cloned, functional influenza-specific cytotoxic T  cells to absorb signifi- 
cant amounts of antibody, implying the absence of the relevent determinants  of 
this T  cell subpopulation (our unpublished observation). 
In  this  report,  we  have  described  a  set  of mAb,  similar  to  those  described 
previously (17, 27, 28), raised across an Igh-1 b allotype barrier,  that have been 
used  to  further  characterize  soluble  factors  derived  from  suppressor  T  cell 
hybridomas. The antibodies identified segregated into two nonoverlapping func- 
tional classes; those reactive with the single-polypeptide chain GAT-TsF1 mole- 
cules, and those reactive with the two-polypeptide chain  TsF2 molecules.  The 
one exception to this observation is the ability of 1322 B 1.3 to absorb both TsFt 
and  TsF2  molecules derived  from  Igh-1 b mice.  This  observation  is  consistent 
with the idea of constant region determinants shared between the two classes of 
suppressor factors, perhaps analogous to the concept of a suppressor determinant. 
Alternatively, this would indicate that  1322 B1.3 is not a true clone, but in fact 
is composed of two separate cell  types with  independent  activities.  This  latter 
possibility  may  be  addressed  most  directly  by  recloning  and  repeating  the 
absorption experiment. An interesting observation to emerge from these data is 
the isotype distribution  among the mAb that  was limited to the IgM and  IgG1 
subclasses.  Furthermore,  those  antibodies  reactive  with  GAT-TsF1  molecules 
were restricted to the lgM subclass, while those reactive with GAT-TsF2 mole- 
cules  were  of  the  IgG1  subclass.  Experiments  are  currently  in  progress  to 
characterize the products of separate fusions of spleen cells from BALB/c mice 
hyperimmunized with C.B20 blasts to determine whether the isotype restriction 
is a  general phenomena,  or reflects the limited size of the sample in the results 
presented here. That this may represent a general phenomena representative of 
this class of serological reagents is suggested by identical observations by Owen 
(16), where only antibodies of the IgM and IgG isotypes were isolated. 
Serologically, some of the anti-IgT-C  reagents  that  we have described react SORENSEN ET  AL.  1055 
with a determinant that segregates with the antigen-binding chain of GAT-TsF2 
molecules,  and  not  with  the  I-J  +  chain.  From  a  serological  standpoint,  the 
structure of the antigen-binding chain is reminiscent of the chains of the antibody 
molecule, where a polymorphic or variable region, capable of binding specifically 
to  antigen,  is  detected  by  antiidiotypic  reagents,  and  a  less  polymorphic  or 
constant  region  is  detected by the  1322  mAb.  The  serologic  reactivity of Ts 
cells, and  more specifically the antigen-binding  chain  of GAT-TsFz,  with anti- 
bodies raised against idiotypic determinants  on anti-GAT antibodies is presum- 
ably crossreactive at the level of the three-dimensional structure of the idiotype, 
since analysis at the nucleic acid level fails to show any bomology by Northern 
or Southern analysis, suggesting that T  cells and B cells do not use the variable 
region genes (15). The GAT-TsF1 molecule is composed of a single polypeptide 
chain,  as  shown  by the  1322  mAb:  the  IgT-C  determinant,  antigen-binding 
portion,  and  I-J determinant  all  cosegregate,  under  reducing  or nonreducing 
conditions, on appropriate immunoabsorbents.  This confirms our previous data 
(9) on the chain structures of the GAT-TsFI and GAT-TsF2 molecules. 
The  1322 mAb were also used to analyze two suppressor T  cell hybridomas, 
372B3.5 and 372D6.5, for the presence of suppressor factor-like activity in the 
cell membranes.  Using an NP-40 extract from sucrose gradient-purified plasma 
membranes,  suppressor activity was recovered from T  cell  hybridomas,  which 
was  reactive  with  1322  mAb.  The  biologically  active  protein  isolated  from 
372D6.5  membranes  had a  molecular mass of 31.5-34  kD, and alone was not 
suppressive. Combination of this protein  with independently isolated I-J  + chain 
from supernatant  fluid derived from  372D6.5  GAT-TsF2,  alone also not sup- 
pressive,  resulted  in  reconstitution  of GAT-specific  suppressor  activity.  This 
result is consistent with data showing the IgT-C determinant recognized by mAb 
1322  C5.3  to  be  on  the  antigen-binding  chain  of  the  secreted  GAT-TsF~ 
molecule. Two implications  follow from these results:  based on these data and 
other studies which show that unfractionated membrane extracts are specifically 
suppressive,  it  appears  that  a  GAT-TsF2-related  structure,  composed  of two 
polypeptide chains associated in a  noncovalent fashion,  exists in the cell mem- 
brane (C. Sorensen and C.  Pierce, manuscript  in preparation).  This result is in 
contrast  to  previous  data  (9,  21)  showing  the  covalent association  of the  two 
chains in hybridoma supernatant  fluid GAT-TsF2, but has precedent in results 
of Taniguchi and colleagues (6), in which a keyhole limpet hemocyanin-specific 
suppressor factor extracted from cells was also shown to exist as two polypeptide 
chains  associated  in  a  noncovalent  fashion.  The  second  point  concerns  the 
apparent molecular mass of the membrane-derived antigen-binding chain, which 
is ~6 kD larger than the secreted antigen-binding chain (26-28 kD) (C. Sorensen 
and C. Pierce, manuscript in preparation).  This difference is consistent with the 
interpretation  that  the  antigen-binding  chain  extracted  from  membranes  is  a 
transmembrane  protein  responsible for the anchoring  the suppressor molecule 
in  the  membrane.  No  differences  in  molecular  mass  were  detected  between 
membrane- and  supernatant-derived  I-J  + chain,  both of which have molecular 
masses of 42-44 kD (data not shown). The existence of two molecular species of 
antigen-binding chains is also suggested by results of mRNA translation  studies, 
in  which  two  independent  mRNA species,  of  11  S  and  17.5  S,  encoding  the 1056  Igh-C-L1NKED  DETERMINANTS  ON  T  SUPPRESSOR  FACTORS 
antigen-binding chain are demonstrated (C. Sorensen and C. Pierce, manuscript 
in preparation). 
The protein isolated from hybridoma 372B3.5 membranes using 1322 A2.1- 
Sepharose  had  a  molecular  mass of 48-50  kD under  nonreducing  conditions, 
and 25 kD under reducing conditions. Similar to the results with the GAT-TsF2- 
producing hybridoma,  the molecule in  the  membrane  of hybridoma  372B3.5, 
which  reacted  with  mAb  1322  A2.1  had  a  greater  molecular  mass  than  its 
supernatant-derived equivalent (19 kD) (8), suggesting that it may be an integral 
membrane  protein.  Unlike  the  GAT-TsF2,  the  molecule  derived  from  the 
membrane  of 372B3.5  suppressed  in  an  antigen-specific  manner,  and  in  the 
absence of additional polypeptide products. The presence of a disulfide bond in 
the membrane-derived  protein  from  372B3.5  is suggested by the reduction  in 
molecular mass in the presence of reducing agents. This observation may indicate 
that  the  membrane-derived  suppressor activity is  unique  from  the  hybridoma 
supernatant  fluid-derived GAT-TsF1,  and  may be due to different content  of 
cysteine  residues.  However,  analysis  at  the  mRNA  level  shows  only a  single 
mRNA species for the suppressive activity isolated from  372B3.5 (31).  Experi- 
ments  are  currently  in  progress  to  investigate  the  relationship  between  the 
membrane-bound and soluble forms of the two suppressor proteins, but the final 
answer requires  isolation of the two molecules independently,  and  comparison 
of their primary sequences. 
The data support the concept of constant region determinants on at least two 
subsets of biologically active proteins derived from T  cells, which may represent 
some form of antigen  receptors.  The prediction  or demonstration  of constant 
region determinants  on or associated with the T  cell receptor for antigen  has 
been suggested by data from several laboratories. Using xenoantisera, Kontiainen 
and Feldmann (32) have shown suppressor factor-specific determinants  shared 
among factors with different antigen specificities. Using reagents similar to those 
reported here, others have also demonstrated allotype-linked determinants pres- 
ent on suppressor cells or suppressor factors with different antigen specificities. 
Biochemical analysis (3) of receptor structures isolated from a variety of human 
cytotoxic T  lymphocyte clones has shown  the  presence  of conserved peptides 
common to all clones, in addition to clonally unique peptides. In studies by Owen 
and  coworkers,  a  single  class  of suppressor  T  cell-restricted  determinants  or 
allotypes, Tsu, with linkage to the Ig allotype locus was identified. Two additional 
determinants  linked to Ig allotype were also described, Tind and Tpre, neither 
of which appear to be expressed on the T  suppressor cells. One interpretation 
of the results reported here is that the suppressor allotype locus is in fact more 
complex,  with possibly two independent  determinants  mapping  to this  region; 
those restricted to the single-chain GAT-TsF1 molecules, and those restricted to 
the antigen-binding  chain of the GAT-TsF2 molecules.  Such an interpretation, 
however,  depends  upon  the  results  of genetic  mapping  studies  currently  in 
progress using several chromosome  12-recombinant mice. Alternative explana- 
tions for our results, such as recognition of alternative glycosylation of a common 
peptide,  do of course exist,  and  have not been ruled out.  If the determinants 
recognized by the  1322 mAb are constant region determinants on suppressor T 
cell  receptors  for  antigen,  one  prediction  is  that  they  should  have  general SORENSEN ET  AL.  1057 
usefulness as reagents for defining specific suppressor T  cell subsets independent 
of antigen specificity or MHC haplotype. One drawback to this potential appli- 
cation(s)  has  been  our  inability to  use  these  reagents  in  immunofluorescent 
studies on normal spleen cell or lymph node populations. These studies were 
done using culture supernatant fluids, and may require further purification of 
the specific antibody for fluorescence to be detectable. Alternatively, these results 
may reflect a normal low-level expression of the relevant determinants on what 
is probably a small subpopulation of the T  cell pool. This is not to say that these 
reagents have no practical use (based on preliminary data  [33  and C.  Pierce, 
manuscript in preparation] suggesting that individual, functionally distinct sub- 
populations of T  cells may be selected using the mAb reported here) as panning 
reagents. 
Summary 
Hyperimmunization of BALB/c mice with concanavalin A-stimulated blasts 
fi'om the Ig allotype-congenic strain, C.B20,  results in the production of anti- 
bodies reactive with T  cells in an allotype-restricted manner. Spleen cells  from 
these hyperimmune BALB/c mice were used to generate a panel of hybridomas 
that secrete monoclonal antibodies, reactive, in an allotype-restricted manner, 
exclusively with T cells subpopulations, and in particular, reactive with suppressor 
T  cell hybridomas and their secreted soluble factors. Two functional classes  of 
antibodies were identified: those that react with single polypeptide-chain sup- 
pressor T  cell factors (TsF1) and the suppressor T  cell hybridomas that produce 
such factors, and those that react with two polypeptide-chain suppressor T  cell 
factors (TsF2) and their corresponding suppressor T  cell hybridomas. These two 
classes  of antibody were used to isolate molecules from the membranes of the 
respective suppressor T  cell hybrids that are functionally and structurally related 
to the secreted suppressor T  cell factors, suggesting a receptor function for these 
molecules. 
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